Bone Health Technologies is developing a new standard of care for treating osteopenia, the precursor to osteoporosis.
Osteoboost has raised $8.0M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Osteoboost's investors include Emmeline Ventures, Portfolia, Good Growth Capital, Golden Seeds, Astia Angels.
Osteoboost is headquartered in San Francisco, United States.
Bone Health Technologies is developing a new standard of care for treating osteopenia, the precursor to osteoporosis.
Osteoboost is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Osteoboost — Funding & Investors." VCBacked, April 9, 2026, https://www.vcbacked.co/company/osteoboost. Accessed September 14, 2026.
VCBacked. (2026). Osteoboost — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/osteoboost
{{cite web |title=Osteoboost — Funding & Investors |url=https://www.vcbacked.co/company/osteoboost |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated